Leukemia is a cancer of the blood cells that most commonly occurs in adults older than 55 and is also the most common cancer in children younger than 15. There are currently more than 300,000 people estimated to be living with or in remission from leukemia in the US.
FDA OKs Hyperkalemia Rx
A new medication could help patients with a serious condition called hyperkalemia.
Hereditary Bleeding Disorder Rx Approved
The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency.
Pradaxa Reversal Rx Approved
The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.
Spreading the Word About Thrombosis
After fracturing her ankle and getting a cast, South African athlete Marie-Victoire Cumming began feeling extreme discomfort in her leg. What she didn't know was that she had a potentially life-threatening condition called deep vein thrombosis.
New Help for Kids with Rare Blood Disorder
Children with a rare blood disorder may soon get new help in the form of a pill.
Rare Blood Disorder Rx Approved for Kids
The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP).
In Early Tests, Blood, Bone Marrow Rx Sparked Hope
Early testing of a medication for blood cancers and bone marrow disorders yielded promising results. Now, researchers are looking to the future.
When Anticoagulants Go Head-to-Head
When two medications have the same effect, a head-to-head trial is often the best way to see which one is more effective.
When More Medication Isn't Necessarily Better
More isn't always better, and that may be especially true when it comes to heart attack medications.